. Author manuscript; available in PMC: 2020 Mar 9.

Published in final edited form as: J Allergy Clin Immunol. 2018 Nov 14;143(5):1752–1759.e6. doi: 10.1016/j.jaci.2018.09.038

TABLE II.

Baseline predictors of clinical asthma remission^*^†

Variable	OR	95% CI	P value
10% Increase in FEV₁/FVC ratio	4.62	3.35–6.50	<.001
Two-fold increase in PC₂₀	1.23	1.09–1.39	.001

Covariates included in the cross-validated model: age, sex, race, CAMP treatment group, clinic site, household income level, history of wheezing with colds, history of exacerbations after exercise, and history of exposure to home tobacco smoke.

^†

Quantitative variables were modeled continuously.